These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16506379)

  • 1. Over-expression of p53 protein in esophageal squamous cell carcinoma of women.
    Nozoe T; Maehara Y
    Hepatogastroenterology; 2006; 53(67):73-6. PubMed ID: 16506379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
    Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF
    Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma.
    Hamada M; Naomoto Y; Shirakawa Y; Yamatsuji T; Noma K; Motoki T; Nobuhisa T; Okawa T; Haisa M; Gunduz M; Matsuoka J; Tanaka N
    Oncol Rep; 2004 Jan; 11(1):57-63. PubMed ID: 14654903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus.
    Nozoe T; Ezaki T; Kabashima A; Baba H; Maehara Y
    Am J Surg; 2005 Jan; 189(1):110-5. PubMed ID: 15701502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
    Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
    Chen XY; Li JS; Liang QP; He DZ; Zhao J
    Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma.
    Hashimoto N; Inayama M; Fujishima M; Shiozaki H
    Hepatogastroenterology; 2007; 54(75):758-60. PubMed ID: 17591056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53 protein in glandular differentiation admixed with squamous cell carcinoma of the esophagus.
    Kuwano H; Sumiyoshi K; Sonoda K; Kitamura K; Tsutsui S; Toh Y; Kitamura M; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):170-4. PubMed ID: 9058139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
    Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between cyclooxygenase-2, CD44v6, and nm23H1 in esophageal squamous cell carcinoma.
    Liu WK; Fu Q; Li YM; Jiang XY; Zhang MP; Zhang ZX
    Onkologie; 2009 Oct; 32(10):574-8. PubMed ID: 19816074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
    Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
    BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma.
    Liu WK; Chu YL; Zhang F; Chen P; Cheng F; Wang H; Jia YY; Ma TY
    Arch Virol; 2005 May; 150(5):991-1001. PubMed ID: 15645378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 in esophageal carcinoma with multiple areas unstained by iodine.
    Yoshikawa M; Kato H; Miyazaki T; Nakajima M; Kamiyama Y; Fukai Y; Tajima K; Masuda N; Ojima H; Tsukada K; Kuwano H
    Hepatogastroenterology; 2005; 52(65):1444-7. PubMed ID: 16201092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray.
    Liu YS; Yu CH; Li L; Zhang BF; Fang J; Zhou Q; Hu Y; Li YM; Jun Gao H
    J Dig Dis; 2007 Aug; 8(3):133-8. PubMed ID: 17650224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
    Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
    Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.